All Articles on Vaccine
Researchers begin trial of nasal spray COVID-19 vaccineKPWHRI is inviting healthy adults to take part — volunteers do not need to be members of Kaiser Permanente.
On the ground with KPWHRI’s flu trackersResearchers Karen Wernli and Erika Kiniry share insights on an exceptional 2024-2025 flu season.
Scientists begin trial of combined COVID-19 and flu vaccineKPWHRI is recruiting Kaiser Permanente Washington members to take part.
Researchers begin trial for high-dose flu vaccineKPWHRI is seeking volunteers ages 50 to 64 who have not received this season’s flu vaccine to join the trial.
Vaccine program recruiting volunteers in Seattle areaKPWHRI’s vaccine registry was the first to enroll participants in a clinical trial of a COVID-19 vaccine.
KPWHRI contributes to new flu vaccine effectiveness resultsInterim data for the 2023-2024 flu season shows that the vaccine has protected all age groups.
Clinical trial will evaluate mpox vaccine for adolescentsThe NIH-sponsored trial will help inform decisions about vaccine approval for 12- to 17-year-olds.
Land Acknowledgment
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.